Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pfizer investigates beta-adrenoceptor agonists

Jan. 17, 1997

Hypoglycemic agents from Nippon Chemiphar

Jan. 17, 1997

New impotence Rx now available in U.S.

Jan. 16, 1997

Approval sought for Androtest-SL

Jan. 16, 1997

Pharmacia & Upjohn's Estring now available on U.S. market

Jan. 16, 1997

Tokyo Tanabe discloses beta3-adrenoceptor agonists

Jan. 16, 1997

Ion exercises option to license sickle cell anemia Rx

Jan. 14, 1997

Canadian launch for antiobesity drug

Jan. 14, 1997

Genetics Institute reports new bone morphogenic protein

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...